What Avantor (AVTR) Said on Its Q3 Earnings Call

Avantor NYSE: AVTR reported a return to organic revenue growth in the third quarter of 2026, led by accelerating performance in its VWR Distribution & Services segment and a return to growth in its Bioscience & Medtech Products business.

MarketBeat • Oct 28, 2026

Avantor, Inc. (AVTR) Q3 2026 Earnings Call Transcript

Avantor, Inc. ( AVTR ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Chris Fidyk - Vice President of Investor Relations Emmanuel Ligner - President, CEO & Director Todd Garner - Executive VP & CFO Steven Eck - Senior VP, Corporate Controller & Chief Accounting Officer Conference Call Participants Casey Woodring - JPMorgan Chase & Co, Research Division Luke Sergott - Barclays Bank PLC, Research Division Douglas Schenkel Tycho Peterson - Jefferies LLC, Research Division Eve Burstein - Bernstein Institutional Services LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good morning. My name is Krista, and I will be your conference operator today.

Seeking Alpha • Oct 28, 2026

Avantor® Reports Third Quarter 2026 Results

Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2% Diluted GAAP EPS of $0.30; adjusted EPS of $0.22 Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow guidance RADNOR, Pa., Oct. 28, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports results that exceeded management's expectations for revenue and adjusted EPS for the third fiscal quarter of 2026.

PRNewsWire • Oct 28, 2026

Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.22 per share a year ago.

Zacks Investment Research • Oct 28, 2026

Avantor appoints new Chief Information Officer

RADNOR, Pa., Oct. 26, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes Mikey Santiago as its new Chief Information Officer.

PRNewsWire • Oct 26, 2026

Longleaf Partners Fund Q3 2026 Portfolio Review

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

Seeking Alpha • Oct 14, 2026

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

AVTR's improving commercial execution, specialty product strength and raised 2026 outlook signal recovery potential despite lingering demand challenges.

Zacks Investment Research • Oct 13, 2026

VTRS vs. AVTR: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Viatris (VTRS) or Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Oct 6, 2026

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, and will hold a related conference call on the same day at 8:00 a.m.

PRNewsWire • Oct 1, 2026

Avantor appoints new Chief Financial Officer

RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.

PRNewsWire • Sep 21, 2026